CareCloud, Inc. (CCLDO)

CareCloud, Inc. (CCLD) reported its Q2 2026 financial results, with revenue increasing to $31.88 million. However, net income attributable to common shareholders fell to $0.18 million, resulting in a diluted EPS of $0, down from $0.04 in the prior year. The company highlighted growth in technology-enabled revenue cycle management, expanded client footprint, and operational progress including AI offerings and cybersecurity incident recovery.

CareCloud Inc (CCLD) reported 16% year-over-year revenue growth in Q2 2026 and achieved its ninth consecutive quarter of positive GAAP net income. Strategic investments in AI, the acquisition of Empower Healthcare, and the full redemption of Series B preferred stock were key highlights. Despite a lower GAAP net income due to these investments, the company anticipates a stronger second half of 2026 driven by seasonality and cross-selling opportunities.

CareCloud (Nasdaq: CCLD) reported a significant increase in its Q2 2026 net revenue to $31.9 million, up from $27.4 million year-over-year, with first-half revenue reaching $63.2 million. This growth was primarily driven by Healthcare IT services and recent acquisitions including Medsphere, RevNu, MAP App, and Empower. Despite higher revenues, net income attributable to common shareholders for H1 2026 resulted in a loss of $0.3 million after preferred dividends. The company also secured a new credit facility with a $40 million term loan and a $10 million revolver, largely used to redeem Series B Preferred Stock.

CareCloud, Inc. (CCLD) reported Q2 earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.07, and revenues of $31.88 million, slightly below expectations. The company has underperformed the market year-to-date, and its stock currently holds a Zacks Rank #3 (Hold), suggesting it is expected to perform in line with the market. Investors are now looking to future earnings calls and estimate revisions to gauge its next moves.

CareCloud, Inc. reported its Q2 2026 financial results, with non-GAAP adjusted EPS of $0.06, matching analyst estimates, and revenue of $31.9M, a 16.0% increase year-over-year. The healthcare IT company saw its adjusted net income reach $2.4M, driven by growing demand for its cloud-based solutions. Management provided a full-year 2026 EPS guidance of $0.20 to $0.23 and revenue guidance of $128.0M to $132.0M, indicating continued positive momentum.